ASTRO Annual Meeting
Whole-breast radiation reduces local recurrence in favorable-risk ductal carcinoma in situ
Whole-breast radiation significantly decreased local recurrence and invasive local recurrence among a subset of women with favorable-riskductal carcinoma in situ, according to data from a randomized study presented at American Society for Radiation Oncology Annual Meeting.
Once-weekly, conventional breast radiotherapy yield similarly low long-term adverse effects
Women with early breast cancer who received once-weekly, hypofractionated radiotherapy exhibited low rates of normal tissue effects comparable to those of conventional radiation therapy at 10 years, according to study findings presented at American Society for Radiation Oncology Annual Meeting.
Proton therapy for pediatric brain tumors yields better cognitive outcomes than X-ray therapy
Proton therapy appeared associated with better neuropsychological outcomes than X-ray radiation therapy among children with brain tumors, according to a study presented at American Society for Radiation Oncology Annual Meeting.
Liquid biopsy test confirms remission in HPV-associated oral cancer
A novel liquid biopsy test showed compelling specificity and sensitivity in detecting HPV DNA among patients who underwent chemoradiotherapy for HPV-associated oropharyngeal squamous cell carcinoma, according to findings presented at the American Society for Radiation Oncology Annual Meeting.
Cisplatin with radiation ‘standard of care’ for HPV-related oral cancers
Chemoradiotherapy produced superior survival outcomes compared with radiation and cetuximab in a cohort of patients with HPV-associated oropharyngeal cancer, according to randomized, phase 3 trial results presented at the American Society for Radiation Oncology Annual Meeting.
Stereotactic ablative radiotherapy for renal cell carcinoma safe in patients with solitary kidney
Stereotactic ablative radiotherapy for renal cell carcinoma produced comparable outcomes among patients with solitary and bilateral kidneys, according to findings presented at the American Society for Radiation Oncology Annual Meeting.
Pelvic lymph node treatment, short-term ADT improve outcomes in prostate cancer
The addition of pelvic lymph node treatment and short-term androgen deprivation therapy to prostate bed salvage radiotherapy reduced risk for disease progression among men with prostate cancer, according to findings from a randomized trial presented at the 2018 American Society for Radiation Oncology Annual Meeting.